
Scientific Publications
< Back to Publications
CK1epsilon is required for breast cancers dependent on beta-catenin activity.
| Publication Type | Journal Article |
| Authors | Kim, SY, Dunn IF, Firestein R., Gupta P., Wardwell L., Repich K., Schinzel AC, Wittner B., Silver SJ, Root DE, Boehm JS, Ramaswamy S., Lander E. S., and Hahn WC |
| Abstract | Aberrant beta-catenin signaling plays a key role in several cancer types, notably colon, liver and breast cancer. However approaches to modulate beta-catenin activity for therapeutic purposes have proven elusive to date. |
| Year of Publication | 2010 |
| Journal | PloS one |
| Volume | 5 |
| Issue | 2 |
| Pages | e8979 |
| Date Published (YYYY/MM/DD) | 2010/02/01 |
| DOI | 10.1371/journal.pone.0008979 |
| PubMed | http://www.ncbi.nlm.nih.gov/pubmed/20126544?dopt=Abstract |




